- Home
- FSTR vs RVNC Comparison
FSTR vs RVNC Comparison
Compare FSTR & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- RVNC
- Stock Information
- Founded
- FSTR 1902
- RVNC 1999
- Country
- FSTR United States
- RVNC United States
- Employees
- FSTR N/A
- RVNC N/A
- Industry
- FSTR Metal Fabrications
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- RVNC Health Care
- Exchange
- FSTR Nasdaq
- RVNC Nasdaq
- Market Cap
- FSTR 272.1M
- RVNC 320.5M
- IPO Year
- FSTR N/A
- RVNC 2014
- Fundamental
- Price
- FSTR $27.82
- RVNC $3.68
- Analyst Decision
- FSTR Hold
- RVNC Hold
- Analyst Count
- FSTR 1
- RVNC 9
- Target Price
- FSTR $25.00
- RVNC $7.78
- AVG Volume (30 Days)
- FSTR 29.0K
- RVNC 2.9M
- Earning Date
- FSTR 03-04-2025
- RVNC 02-26-2025
- Dividend Yield
- FSTR N/A
- RVNC N/A
- EPS Growth
- FSTR N/A
- RVNC N/A
- EPS
- FSTR 3.85
- RVNC N/A
- Revenue
- FSTR $537,459,000.00
- RVNC $256,945,000.00
- Revenue This Year
- FSTR $0.44
- RVNC $11.28
- Revenue Next Year
- FSTR $7.16
- RVNC $27.21
- P/E Ratio
- FSTR $7.22
- RVNC N/A
- Revenue Growth
- FSTR N/A
- RVNC 25.82
- 52 Week Low
- FSTR $14.23
- RVNC $2.30
- 52 Week High
- FSTR $30.77
- RVNC $7.56
- Technical
- Relative Strength Index (RSI)
- FSTR 57.45
- RVNC 61.76
- Support Level
- FSTR $24.63
- RVNC $3.25
- Resistance Level
- FSTR $28.08
- RVNC $3.38
- Average True Range (ATR)
- FSTR 0.87
- RVNC 0.08
- MACD
- FSTR 0.03
- RVNC 0.08
- Stochastic Oscillator
- FSTR 92.46
- RVNC 97.01
About FSTR L.B. Foster Company
L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through three segments: Rail Technologies and Services; Precast Concrete Products and Steel Products and Measurement. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.